While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.
What: Shares of UnitedHealth Group (NYSE:UNH) fell 2% in pre-market trading Thursday after Jefferies downgraded the health insurance giant from buy to hold.
So what: Along with the downgrade, analyst David Windley reiterated his price target of $87, representing just 5% worth of upside to yesterday's close. So while momentum traders might be turned off by UnitedHealth's price strength in recent months, Windley's call could reflect a sense on Wall Street that the company's valuation is becoming a bit stretched.
Now what: According to Jefferies, UnitedHealth's risk/reward trade-off isn't too attractive at this point. "UNH's premium to large cap peers has widened to nearly 2.5x vs historical 1.5-1.8x average. We believe the multiple stays flat at best given below-peer EPS growth (flat and 9% vs peers at 8% and 11% in 2014/15, respectively)," said Windley. "While Optum is performing very well, we believe the best case UNH EPS growth for '15 is in line with peers and likely below. We do not have specific fears about UNH's 2Q, but do not expect significant upside." When you couple UnitedHealth's still-reasonable forward P/E in the low teens with its durable competitive moat, however, long-term shareholders might want to take that short-term bearishness with a grain of salt.
Top dividend stocks for the next decade -- Is UnitedHealth one?
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.
Brian Pacampara has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.